2-Piperidinecarboxylicacid,1-[oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]acetyl]-,monosodium salt, [2R-[2a,2(S),3a,6b[2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R,22(1S,3R,4R*)]]]-(9CI) (148554-65-8)

Identification
Name:	2-Piperidinecarboxylicacid,1-[oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]acetyl]-,monosodium salt, [2R-[2a,2(S),3a,6b[2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R,22(1S,3R,4R*)]]]-(9CI)
Synonyms:	SECO RAPAMYCIN SODIUM SALT
CAS:	148554-65-8
Molecular Formula:	C51H79 N O13 . Na
Molecular Weight:	0
InChI:	InChI=1/C51H79NO13.Na/c1-31(26-35(5)45(55)47(64-10)46(56)36(6)28-34(4)41(53)23-19-32(2)27-38-21-24-42(54)44(29-38)63-9)16-12-11-13-17-33(3)43(62-8)30-39-22-20-37(7)51(61,65-39)48(57)49(58)52-25-15-14-18-40(52)50(59)60;/h11-13,16-17,19,23,28,31-32,34-35,37-40,42-44,46-47,54,56,61H,14-15,18,20-22,24-27,29-30H2,1-10H3,(H,59,60);/q;+1/p-1/b13-11+,16-12+,23-19-,33-17+,36-28+;/t31-,32+,34-,35-,37-,38+,39+,40+,42-,43+,44-,46-,47+,51-;/m1./s1
Molecular Structure:
Properties
Usage:	A metabolite of Sirolimus
Safety Data